JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Activity
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, D. K.
Journal of Nuclear Medicine Technology Volume 31, Number 4, 2003 196-201
© 2003 by Society of Nuclear Medicine


CONTINUING EDUCATION

Nuclear Medicine and Infection Detection: The Relative Effectiveness of Imaging with 111In-Oxine-, 99mTc-HMPAO-, and 99mTc-Stannous Fluoride Colloid-Labeled Leukocytes and with 67Ga-Citrate*

Davina K. Hughes, B.App.Sci. (MRS-Nuc Med)

School of Medical Radiation Sciences, University of Sydney, Sydney, New South Wales, Australia

ABSTRACT

With a current annual mortality rate of around 35% worldwide, infection remains a significant concern, and the diagnosis and localization of infectious foci is an important health issue. As an established infection-imaging modality, nuclear medicine plays a vital health-care role in the diagnosis and subsequent effective treatment of this condition. Despite the development of several newer radiopharmaceuticals, 67Ga and leukocyte imaging procedures have maintained their established place for infection. Several techniques in nuclear medicine significantly aid infection diagnosis, including imaging with 111In-oxine-, 99mTc-hexamethylpropyleneamine oxime-, and 99mTc-stannous fluoride colloid-labeled leukocytes and with 67Ga-citrate. Each radiopharmaceutical has specific advantages and disadvantages that make it suitable to diagnose different infectious processes (e.g., soft-tissue sepsis, inflammatory bowel disease, osteomyelitis, occult fever, fever of unknown origin, and infections commonly found in immunocompromised patients). After finishing this article, the reader should be able to identify the properties of an ideal radiopharmaceutical for infection imaging, list a range of available infection-imaging radiopharmaceuticals, compare the relative results of a range of radiopharmaceuticals used internationally to detect infection in the body, understand several common infectious processes that can be diagnosed using nuclear medicine techniques, and select an appropriate radiopharmaceutical to image a range of infectious processes.

Key Words: infection; 67Ga; 111In; HMPAO; colloid




This article has been cited by other articles:


Home page
JNMHome page
J. E.M. van Eerd, M. Broekema, T. D. Harris, D. S. Edwards, W. J.G. Oyen, F. H.M. Corstens, and O. C. Boerman
Imaging of Infection and Inflammation with an Improved 99mTc-Labeled LTB4 Antagonist
J. Nucl. Med., September 1, 2005; 46(9): 1546 - 1551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2003 by the Society of Nuclear Medicine Technologist Section.